Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
84 studies found for:    Open Studies | "Bone Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Thermal Testing in Bone Pain (TiBoP)
Conditions: Cancer Induced Bone Pain;   Secondary Malignant Neoplasm of Bone;   Toxicity Due to Radiotherapy;   Pain
Intervention: Other: Clinical biomarker (thermal sensory testing)
22 Recruiting The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy
Conditions: Mammary Cancer;   Lymphoma;   Bone Tumour;   Gynecological Tumors
Intervention: Drug: PEG-rhG-CSF
23 Recruiting Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
Condition: Tumor With Bone Metastasis
Interventions: Other: quality of life questionaries;   Drug: intravenous or oral bone antiresorptive treatments
24 Recruiting Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Conditions: Prostate Cancer;   Bone Metastases
Intervention: Drug: [68Ga]P15-041
25 Recruiting A Study to Collect Data About Analgesia in Patients With Bone Metastasis
Condition: Bone Metastasis
Interventions: Other: Questionnaires completion;   Other: Clinical Pain Assessments
26 Recruiting The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones
Condition: Bone Metastasis
Interventions: Procedure: Stabilisation of (impending) pathological fracture;   Radiation: Radiotherapy of bone metastasis
27 Recruiting Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy
Condition: Bone Metastasis
Interventions: Drug: fentanyl transmucosal;   Drug: Placebo
28 Recruiting Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS
Condition: Bone Metastases
Intervention: Radiation: Radiotherapy
29 Recruiting Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Condition: Bone Metastases
Intervention: Other: blood sampling, the SF-36 questionnaire
30 Recruiting Biological Image Guided Antalgic Stereotactic Body Radiotherapy of Bone Metastases
Condition: Bone Metastases
Interventions: Radiation: Conventional Radiotherapy;   Radiation: Biological image-guided radiotherapy with conventional dose.;   Radiation: Biological image-guided SBRT with dose-escalation.
31 Recruiting Image-guided Cryoablation of Head, Neck and Spine Tumors
Conditions: Head and Neck Neoplasms;   Malignant Neoplasm of Vertebral Column
Interventions: Procedure: Cryoablation;   Device: Biopsy
32 Recruiting The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)
Condition: Secondary Malignant Neoplasm of Vertebral Column
Intervention:
33 Recruiting Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
Conditions: Breast Carcinoma;   Cancer Survivor;   Depression;   Fatigue;   Leukemia;   Lymphoma;   Malignant Bone Neoplasm;   Malignant Digestive System Neoplasm;   Malignant Female Reproductive System Neoplasm;   Malignant Male Reproductive System Neoplasm;   Pain;   Sleep Disorder;   Soft Tissue Sarcoma
Interventions: Procedure: Management of Therapy Complications;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Behavioral: Telephone-Based Intervention
34 Not yet recruiting Lenvatinib and Capecitabine in Patients With Advanced Malignancies
Conditions: Advanced Cancer;   Malignant Neoplasm of Breast;   Malignant Neoplasms of Bone and Articular Cartilage;   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites;   Malignant Neoplasms of Independent (Primary) Multiple Sites;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Male Genital Organs;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs;   Malignant Neoplasms of Thyroid and Other Endocrine Glands;   Malignant Neoplasms of Urinary Tract
Interventions: Drug: Lenvatinib;   Drug: Capecitabine
35 Recruiting Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Conditions: Bone Cancer;   Chondrosarcoma;   Ewing's Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Bone Necrosis;   Bone Sarcoma;   Osteomyelitis
Interventions: Drug: Feraheme;   Procedure: MR Scan
36 Recruiting A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Castration-resistant Prostate Cancer;   Castration-resistant Prostate Cancer Metastatic to Bone
Interventions: Procedure: Blood Tests;   Procedure: CT scan and bone scan;   Procedure: FACBC PET/MRI in a subset of participants
37 Recruiting Efficacy of Radiotherapy in Combination With Zoledronic Acid on Pain Relief in Bone Metastasis Patients
Conditions: Bone Metastasis;   Gastrointestinal Cancer
Intervention: Drug: Zoledronic acid
38 Not yet recruiting Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC
Condition: Castrate Resistant Prostate Cancer With Bone Metastasis
Interventions: Drug: Amorphous calcium carbonate;   Other: Placebo
39 Recruiting Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases
Conditions: Prostate Cancer;   Bone Metastases;   Prostate Neoplasms
Interventions: Drug: LHRH agonist/antagonist;   Drug: Bicalutamide;   Radiation: Radium-223 dichloride
40 Recruiting Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer
Conditions: Breast Cancer;   Prostate Cancer;   Bone Metastases
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.